SC
SNPS icon

Solstein Capital’s Synopsys SNPS Stock Holding History

Solstein Capital’s Portfolio SNPS Stock Details SNPS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11
Closed -$5.43K – 497
2025
Q3 		$5.43K Buy
+11
New +$6.22K ﹤0.01% 372

Other funds holding SNPS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
NC
Nvidia Corp Santa Clara, California $18.4B AUM 362.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Solstein Capital's SNPS Position: Q4 2025 in Review

Solstein Capital sold out of Synopsys (SNPS) in Q4 2025, closing a stake of 11 shares — an estimated $5.43K sold.

Solstein Capital first reported a position in SNPS in Q3 2025 and held it in 1 quarter. The position peaked at $5.43K in Q3 2025. 1,406 funds tracked by Wall St. Rank hold SNPS as of Q4 2025.

  • Solstein Capital reported no remaining Synopsys position as of Q4 2025 after selling out during the quarter.
  • Solstein Capital sold 11 Synopsys shares in Q4 2025, an estimated $5.43K.
  • Solstein Capital first reported a position in Synopsys in Q3 2025 and held it in 1 quarter.
  • Solstein Capital's Synopsys position peaked at $5.43K in Q3 2025.
  • 1,406 funds tracked by Wall St. Rank held Synopsys as of Q4 2025.

Based on Solstein Capital's 13F filing for Q4 2025, filed 13 Feb 2026.